🚨 BOMBSHELL: New FOIA Documents Reveal the COVID Pandemic Was a DoD Operation Dating Back to Obama
"The Pentagon controlled the COVID-19 program from the very beginning and everything we were told was political theater to cover it up right down to the FDA vaccine approval"
So many leaks and knife fights at the Whitehouse they will need a mythical Jewish plumber to stop it all.
It's not just Trump that has been sabotaged. This has been an attack on the America first movement.
I don't think it's going to work out like they think it will.
Good luck
Long Live the Republic
@packingpatriot_@HappyCamper2626 Left moved to states they can take majority in election. They studied this and moved ranks around to boost their wins. Many Islamic unregistered foreigners help tip the scale.
They called it a wave. Waves have a shape. This has a signature.
25 points in Texas. 24 in Iowa. 22 in South Carolina. 21 in Kansas. The redder the state, the deeper the swing — while actual swing states barely moved.
That’s not how voters work. That’s the tell.
Buckle up. This is just getting started. 🔥 🇺🇸 🫡 #TRUMP2028
While i do enjoy the finger pointing and resignations.
Remember it's not just one person's fault, it's all of the cowardly zionists in Trump's administration. Every last wall kisser must be expelled from our government before we can reclaim our sovereignty and reclaim our Republic.
Good luck
Long Live The Republic
🚨 “Chemo Can’t Kill These Cells, But Ivermectin Can”. Dr. William Makis explains how
In this interview, Dr. William Makis discusses why he believes repurposed antiparasitic medicines deserve more attention in cancer research.
His focus is not simply on whether ivermectin affects cancer cells, but how it may interact with them at the molecular level.
🦠 IVERMECTIN AND CANCER STEM CELLS
Dr. Makis highlights research on ivermectin's effects on cancer stem cells, which are a specific population of cells studied for their potential role in recurrence and treatment resistance.
He argues that this could theoretically complement treatments that primarily target rapidly dividing tumor cells.
Another mechanism he discusses is multidrug resistance. Cancer cells can use molecular pumps to reduce drug concentrations inside the cell.
He says preclinical research has investigated whether ivermectin can interfere with these mechanisms and potentially make cancer cells more susceptible to treatment.
🤔 What about Fenbendazole and Mebendazole?
The discussion also turns to other antiparasitic drugs.
Dr. Makis describes research examining fenbendazole and mebendazole and their effects on glucose transport and cancer cell metabolism.
The underlying idea is simple:
"Cancer cells need energy to grow".
Research has investigated whether disrupting glucose uptake can interfere with tumor cell growth.
⚠️ The bigger drug repurposing question
These mechanisms are primarily being investigated in preclinical research, including laboratory and animal studies. They are not the same as clinical evidence showing that these drugs treat cancer in patients.
But that's precisely why the research remains interesting.
Ivermectin, fenbendazole, and mebendazole are established antiparasitic medicines, and researchers continue to investigate whether some of their biological mechanisms could have applications beyond their original uses.
⚠️ Follow me on my official telegram channel https://t.co/FrJ4YkA0Az for more conversations and research around ivermectin, cancer, and repurposed medicines.
@ImFiredUp2@SweetPeaJeepher She had become ship sank, she got nutty as shit lately. She lost me months ago. Sounds like she likes ladies that her their children.
🚨 “MY ONCOLOGIST IS SHOCKED.” DR. WILLIAM MAKIS ON FENBENDAZOLE, STAGE 4 CANCER & REPURPOSED DRUGS
What happens when patients who had already gone through multiple lines of chemotherapy start coming back with a very different story?
According to Dr. William Makis, this is what caught his attention.
He discusses Fenbendazole, Mebendazole and other repurposed drugs in the context of difficult Stage 4 cancers, including patient experiences he says he encountered repeatedly.
🔥 The story that started it
Makis discusses Joe Tippens, who was diagnosed with Stage 4 small cell lung cancer, an aggressive form of cancer.
According to Makis, Tippens received a less than 1% five year survival estimate.
He was placed on Keytruda, an immune checkpoint inhibitor.
Then came Fenbendazole.
Makis says Tippens later reported becoming cancer free and remaining so years later.
That less than 1% survival estimate is what makes the story so striking, and it became one of the stories that pushed Makis to look more closely at repurposed medicines and cancer research.
🧬 Then Makis looked at the research
Makis says there is a growing body of preclinical research on Fenbendazole.
He also discusses published cases involving patients with advanced cancer who had previously failed multiple chemotherapy regimens.
According to Makis, these patients subsequently experienced major improvements after using Fenbendazole.
📈 And then the patient stories kept coming
Makis describes patients returning to him saying:
“My cancers are shrinking.”
He says some told him their oncologists were shocked by what they were seeing.
He describes reports involving:
• Stage 4 pancreatic cancer
• Cholangiocarcinoma
• Ovarian cancer
• Small cell lung cancer
He also discusses patients whose tumors reportedly shrank despite having already failed multiple lines of chemotherapy.
💊 The bigger conversation
This is where Makis connects Fenbendazole, Mebendazole, Ivermectin and other repurposed medicines to a broader cancer research discussion.
His argument is that existing medicines deserve serious investigation for potential applications beyond their original indications.
And his final message is especially striking:
“I think repurposed drugs can give patients hope in situations that are very dire.”
That is the bigger question behind the conversation:
How many existing medicines could have unexplored potential in cancer research?
The stories are fueling growing interest in Fenbendazole, Mebendazole, Ivermectin and drug repurposing, and that conversation is becoming increasingly difficult to ignore.
📌 SAVE this breakdown for the Fenbendazole and repurposed medicine discussion.
🔄 REPOST if you think overlooked medicines deserve more serious cancer research.
💊 Looking for Fenbendazole or Mebendazole? Find repurposed drugs at @rxmeds_store with worldwide delivery.
#Fenbendazole #Mebendazole #Ivermectin #CancerResearch #Stage4Cancer #RepurposedDrugs #Oncology #CancerResearch
We found 84% of cancer patients treated with ivermectin + mebendazole saw their cancer COMPLETELY DISAPPEAR, SHRINK, or STOP SPREADING after 6 months.
The Chemotherapy Cartel is in FULL PANIC MODE.
A major legal obstacle just struck down.
Previously, the Second Circuit barred organizations like GOA from suing on behalf of their members.
We can now once again bring cases against anti-gun states in the Second Circuit, like NY, to defend our members’ constitutional rights.
BREAKING: Massive MAHA Coalition Representing 63 MILLION Followers Sends Open Letter to Trump and RFK Jr. Demanding REMOVAL of the mRNA Platform
168 prominent physicians, scientists, lawmakers, and public figures unite behind six demands for sweeping federal action:
1. BAN mRNA/gene-therapy-derived technologies for all vaccines
2. TERMINATE the PREP Act declaration for COVID injections
3. REPEAL the PREP Act
4. BAN pharmaceutical direct-to-consumer advertising
5. END federal healthcare incentives that promote medical coercion
6. END conflicts of interest at the CDC, FDA, NIH, and NIAID
I’m proud to stand among the signatories putting our names behind these demands.
@DrStefan_ Cure is not 5$ far more, because U.S. suppliers just like oil suppliers run up the cost to ridiculous amount, they should be ashamed of themselves, and black balled.